This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Trubion Pharmaceuticals, Inc. And Its Board Of Directors

Levi & Korsinsky, LLP announces that on October 4, 2010, they filed a class action complaint on behalf of all current stockholders of Trubion Pharmaceuticals, Inc. (“Trubion”) (NASDAQ: TRBN) in connection with Trubion’s attempt to merge with Emergent BioSolutions Inc. (“Emergent”) (NYSE: EBS). The complaint charges Trubion and Trubion’s board of directors with, among other things, violations of the Securities Exchange Act of 1934 and Rule 14a-9. In particular, the complaint alleges that the defendants have issued materially false and misleading statements regarding the proposed transaction wherein Trubion intends to merge with Emergent.

If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiffs’ counsel, Eduard Korsinsky, at Levi & Korsinsky, LLP, (212) 363-7500 or, or via e-mail at ek@zlk.com. If you are a member of this class, you can view a copy of the complaint as filed or join this class action online at http://www.zlk.com. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. AT THIS TIME YOU MAY DO NOTHING AND REMAIN AN ABSENT CLASS MEMBER. YOU MAY ALSO RETAIN COUNSEL OF YOUR CHOICE.

Levi & Korsinsky, LLP is a national law firm that represents the rights of shareholders and victims of corporate abuse. We are headquartered in New York City and have offices in Los Angeles, California and New Jersey. With over 50 years of combined litigation experience, the members of L|K have been involved in hundreds of class action lawsuits and have obtained multi-million dollar recoveries. L|K has been appointed lead counsel or has played a major role on behalf of shareholders in a majority of the merger-related lawsuits that have been filed on behalf of shareholders throughout the country. The firm has therefore developed a specialization of knowledge in shareholder rights and fiduciary duty law.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs